Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I H Hall

Showing results (131-140 of 288) with videos related to

Pageof 29
Sort By:
Biochemical Pharmacology|May 30, 2001
Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell deathB J Barnes, A E Eakin, R A Izydore, et al.
Anti-Cancer Drugs|April 1, 1993
The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxidesD X West, A E Liberta, K G Rajendran, et al.
Biochemistry|November 6, 1984
Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonateW L Williams, S G Chaney, I H Hall, et al.
Journal of Pharmaceutical Sciences|July 1, 1983
Hypolipidemic activity of substituted 2-pyrrolidinones in rodentsG H Cocolas, J M Chapman, P J Voorstad, et al.
Pharmaceutical Research|February 1, 1987
Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodentsA R Murthy, O T Wong, D J Reynolds, et al.
Anticancer Research|May 5, 1999
Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cellsI H Hall, R A Izydore, A E Warren, et al.
Anticancer Research|November 1, 1996
Boron substituted deoxyribonucleosides as cytotoxic agentsI H Hall, A Elkins, A Sood, et al.
Biochemistry|November 15, 2000
Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-dionesB J Barnes, A E Eakin, R A Izydore, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenaseB J Barnes, R A Izydore, A E Eakin, et al.
Journal of Pharmaceutical Sciences|November 1, 1983
Anti-inflammatory agents III: Structure-activity relationships of brusatol and related quassinoidsI H Hall, K H Lee, Y Imakura, et al.
Pageof 29

Showing results (131-140 of 288) with videos related to

Sort By:
Pageof 29
Biochemical Pharmacology|May 30, 2001
Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell deathB J Barnes, A E Eakin, R A Izydore, et al.
Anti-Cancer Drugs|April 1, 1993
The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxidesD X West, A E Liberta, K G Rajendran, et al.
Biochemistry|November 6, 1984
Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonateW L Williams, S G Chaney, I H Hall, et al.
Journal of Pharmaceutical Sciences|July 1, 1983
Hypolipidemic activity of substituted 2-pyrrolidinones in rodentsG H Cocolas, J M Chapman, P J Voorstad, et al.
Pharmaceutical Research|February 1, 1987
Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodentsA R Murthy, O T Wong, D J Reynolds, et al.
Anticancer Research|May 5, 1999
Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cellsI H Hall, R A Izydore, A E Warren, et al.
Anticancer Research|November 1, 1996
Boron substituted deoxyribonucleosides as cytotoxic agentsI H Hall, A Elkins, A Sood, et al.
Biochemistry|November 15, 2000
Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-dionesB J Barnes, A E Eakin, R A Izydore, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenaseB J Barnes, R A Izydore, A E Eakin, et al.
Journal of Pharmaceutical Sciences|November 1, 1983
Anti-inflammatory agents III: Structure-activity relationships of brusatol and related quassinoidsI H Hall, K H Lee, Y Imakura, et al.
Pageof 29